Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial

Fertility and Sterility

Volumn 90, Issue 6, 2008, Pages 2190-2195

  Serna, José ^a   Cholquevilque, José L ^a   Cela, Vito ^b   Martínez Salazar, Javier ^a   Requena, Antonio ^a   Garcia Velasco, Juan A ^a,c  

^a IVI Madrid   (Spain)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

corpus luteum function; estradiol IVF; implantation; Luteal phase support

Indexed keywords

ESTRADIOL; PROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE SUBSTITUTION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPERM DONOR;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVAGINAL; ADULT; DRUG THERAPY, COMBINATION; EMBRYO IMPLANTATION; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; LUTEAL PHASE; OOCYTE RETRIEVAL; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; PROGESTERONE; PROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 56949084215     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.021     Document Type: Article

References (24)

1. Soliman S., Daya S., Collins J., and Hughes E.G. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 61 (1994) 1068-1076
2. Engmann L., Diluigi A., Schmidt D., Benadiva C., Maier D., and Nulsen J. A prospective randomized trial evaluating the effect of luteal phase estradiol supplementation on the success of IVF treatment. Fertil Steril 84 (2005) S88
3. Fatemi H., Kolibianakis E., Camus M., Tournaye H., Donoso P., Papanikolau P., et al. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod 21 (2006) 2628-2632
4. Lewin A., Benshushan A., Mezker E., Yanai N., Schenker J.G., and Goshen R. The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support. Fertil Steril 62 (1994) 121-125
5. Pritts E., and Atwood A. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 17 (2002) 2287-2299
6. Smitz J., Bourgain C., Van Waesberghe L., Camus M., Devroey P., and Van Steirteghem A. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and hMG induced superovulation. Hum Reprod 8 (1993) 40-45
7. Tay P., and Lenton E. Inhibition of progesterone secretion by oestradiol administered in the luteal phase of assisted conception cycles. Med J Malaysia 58 (2003) 187-195
8. Gleicher N., Brown T., Dudkiewicz A., Karande V., Rao R., Balin M., et al. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles-but only in younger women. Early Pregnancy 4 (2000) 64-73
9. Gorkemli H., Ak D., Akyurek C., Aktan M., and Duman S. Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles. Gynecol Obstet Invest 58 (2004) 140-144
10. Hurd W., Randolph Jr. J., Christman G., Ansbacher R., Menge A., and Gell J. Luteal support with both estradiol and progesterone after clomiphene citrate stimulation for in vitro fertilization. Fertil Steril 66 (1996) 587-592
11. Lukaszuk K., Liss J., Lukaszuk M., and Maj B. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 83 (2005) 1372-1376
12. Vlahos N., Lipari C., Bankowski B., Lai T., King J., Shih I., et al. Effect of luteal phase support on endometrial L-selectin ligand expression following recombinant follicle stimulating hormone and ganirelix acetate for in vitro fertilization. J Clin Endocrinol Metab 91 (2006) 4043-4049
13. Farhi J., Weissman A., Steinfeld Z., Shorer M., Nahum H., and Levran D. Estradiol supplementation during the luteal phase may improve the pregnancy rates in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 73 (2000) 761-766
14. Adams S., Terry V., Hosie M., Gayer N., and Murphy C. Endometrial response to IVF hormonal manipulation: comparative analysis of menopausal, down regulated and natural cycles. Reprod Biol Endocrinol 2 (2004) 21
15. De Ziegler D., Bergeron C., Cornel C., Medalie D., Massai M., Milgrom E., et al. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab 74 (1992) 322-331
16. Beckers N., Macklon N., Eijkemans M., Ludwig M., Ferberlbaum R., Diedrich K., et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 88 (2003) 4186-4192
17. Beckers N., Platteau P., Eijkemans M., Macklon N., De Jong F., Devroey P., et al. The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eur J Endocrinol 155 (2006) 355-363
18. Henzl M., and Loomba P. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. J Reprod Med 48 (2003) 525-540
19. 2 administration: effects on endometrial thickness, uterine perfusion, and contractility. Fertil Steril 76 (2001) 994-998
20. Yen S., Martin P., Burnier A., Czekala N., Greaney Jr. M., and Callantine M. Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17-beta estradiol in postmenopausal women. J Clin Endocrinol 40 (1975) 518-521
21. Hung E., Shu W., Yee E., Wai W., and Chung P. A rapid decline in serum oestradiol concentrations around the mid-luteal phase had no adverse effect on outcome in 763 assisted reproduction cycles. Hum Reprod 15 (2000) 1903-1908
22. Valbuena D., Martin J., de Pablo J.L., Remohi J., Pellicer A., and Simón C. Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril 76 (2001) 962-968
23. Forman R., Eychenne B., Nessmann C., Frydman R., and Robel P. Assesing the early luteal phase in in vivo fertilization cycles: relationships between plasma steroids, endometrial receptors, and endometrial histology. Fertil Steril 51 (1999) 310-316
24. Friedler S., Zimerman A., Schachter M., Raziel A., Strassburguer D., and Ron El R. The midluteal decline in serum estradiol levels is drastic but not deleterious for implantation after in vitro fertilization and embryo transfer in patients with normal or high responses. Fertil Steril 83 (2005) 54-60